Epigenetic reprogramming and hypothalamic changes in metabolic syndrome

FHS
July 30, 2024
6:11 pm

Metabolic syndrome (MetS) is a multifaceted disorder that impacts approximately 20–25% of the global population.

Dementia Risk Dropped With Anti-Inflammatory Diet for Certain Patients

An anti-inflammatory diet was associated with lower dementia risk in adults with cardiometabolic diseases. Over 12 years, dementia risk was 31% lower for those who

August 13, 2024

Bevacizumab by F. Hoffmann-La Roche for Small-Cell Lung Cancer: Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

May 17, 2024

European Union Grants €6.5M for Multi-Site Psilocybin Study in Palliative Patients – Psychedelic Alpha

Psilocybin therapy has shown promise in improving psycho-spiritual wellbeing in patients with life-threatening cancer, as demonstrated by Griffiths et al. (2016), Shnayder et al. (2023),

January 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.